Chemical Structure (Cerebyx 01)
Cerebyx Injection, Solution
Product Images NDC 0069-6001
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cerebyx (NDC 0069-6001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Cerebyx 02)
Logo (Cerebyx 03)
The text is describing a product called "Injectables" distributed by Plizer Labs, which is a division of Pfizer Inc, located in New York City.*
Principal Display Panel (10 mL Vial Label)
This is a description of a medication called Cerebyxe, which is an injection containing fosphenytoin sodium. Each vial of the medication contains 750mg of fosphenytoin sodium, equivalent to 500mg of phenytoin sodium. The medication is stored under refrigeration between 2°C and 8°C. The dosage and administration of Cerebyxe differs from parenteral phenytoin. More information about dosage and use can be found in the package insert. The medication is distributed by Pfizer Labs, a division of Pfizer Inc. Cerebyxe is a single-dose injection and is used for intramuscular or intravenous administration.*
Principal Display Panel (10 mL Vial Package)
This is a description of a medication called "Cerebyxe". The medication comes in a box containing 10 single-dose vials, and is for intramuscular or intravenous use. Each vial contains 10 ml of fosphenytoin sodium injection, with 500 mg PE/10 mL (50 mg PE/mL). The medication is designed to treat seizures and contains phenytoin sodium equivalents. The package insert provides further details, including dosages, administration instructions, and warnings about storage and disposal.*
Principal Display Panel (2 mL Vial Label)
Cerebyxe is an injection medication containing fosphenytoin sodium 150mg equivalent to phenytoin sodium 100mg. It is intended for intramuscular or intravenous use and each vial is a 2 mL Single-dose preparation. Detailed dosage and usage information can be obtained from the package insert. It is distributed by Pfizer Labs and has an NDC code of 0069-6001-02.*
Principal Display Panel (2 mL Vial Carton)
Cerebyx (fosphenytoin sodium) Injection is a medication that comes in 25 single-dose vials (2 ml each), containing 50mg to 100mg phenytoin sodium equivalents per milliliter. Each vial also contains Tromethamine, USP (TRIS) 1.1 Molar, as a buffer to adjust pH and water for injection, USP. Cerebyx is stored at a temperature between 2°C to 8°C. The dosage of Cerebyx is expressed in phenytoin sodium equivalents. Dosage and administration instructions must only be given after the doctor's prescription. Unused product must be discarded after opening.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
